Tech Company Financing Transactions

Sight Sciences Funding Round

Sight Sciences secured a $30 million Series E investment round on 3/19/2020. Investors included D1 Capital Partners and private investors.

Transaction Overview

Company Name
Announced On
3/19/2020
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series E
Investors

D1 Capital Partners (Lead Investor) (James Rogers)

Proceeds Purpose
Proceeds will be used for continued clinical and operational development and to support commercial expansion for Sight Sciences' OMNI and TearCare products.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
4040 Campbell Ave. 100
Menlo Park, CA 94025
USA
Email Address
Overview
Sight Sciences, Inc. is a privately held ophthalmic medical device company whose mission is to revolutionize how we think about and treat the leading causes of eye disease.
Profile
Sight Sciences LinkedIn Company Profile
Social Media
Sight Sciences Company Twitter Account
Company News
Sight Sciences News
Facebook
Sight Sciences on Facebook
YouTube
Sight Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Badawi
  Paul Badawi LinkedIn Profile  Paul Badawi Twitter Account  Paul Badawi News  Paul Badawi on Facebook
Chief Financial Officer
Jesse Selnick
  Jesse Selnick LinkedIn Profile  Jesse Selnick Twitter Account  Jesse Selnick News  Jesse Selnick on Facebook
Chief Medical Officer
Reay Brown
  Reay Brown LinkedIn Profile  Reay Brown Twitter Account  Reay Brown News  Reay Brown on Facebook
Chief Technical Officer
David Badawi
  David Badawi LinkedIn Profile  David Badawi Twitter Account  David Badawi News  David Badawi on Facebook
Vice President
Jessica Holmes
  Jessica Holmes LinkedIn Profile  Jessica Holmes Twitter Account  Jessica Holmes News  Jessica Holmes on Facebook
Vice President
Chris Pike
  Chris Pike LinkedIn Profile  Chris Pike Twitter Account  Chris Pike News  Chris Pike on Facebook
Vice President
Richard Rush
  Richard Rush LinkedIn Profile  Richard Rush Twitter Account  Richard Rush News  Richard Rush on Facebook
VP - Bus. Development
Shawn O'Neil
  Shawn O'Neil LinkedIn Profile  Shawn O'Neil Twitter Account  Shawn O'Neil News  Shawn O'Neil on Facebook
VP - Manufacturing
John Ordway
  John Ordway LinkedIn Profile  John Ordway Twitter Account  John Ordway News  John Ordway on Facebook
VP - Marketing
Todd Love
  Todd Love LinkedIn Profile  Todd Love Twitter Account  Todd Love News  Todd Love on Facebook
VP - Marketing
James Sluck
  James Sluck LinkedIn Profile  James Sluck Twitter Account  James Sluck News  James Sluck on Facebook
VP - Marketing
Patrick Smale
  Patrick Smale LinkedIn Profile  Patrick Smale Twitter Account  Patrick Smale News  Patrick Smale on Facebook
VP - R & D
Daniel O'Keeffe
  Daniel O'Keeffe LinkedIn Profile  Daniel O'Keeffe Twitter Account  Daniel O'Keeffe News  Daniel O'Keeffe on Facebook
VP - Regulatory Affairs
Ingrid Kane
  Ingrid Kane LinkedIn Profile  Ingrid Kane Twitter Account  Ingrid Kane News  Ingrid Kane on Facebook
VP - Sales
Aaron Capsel
  Aaron Capsel LinkedIn Profile  Aaron Capsel Twitter Account  Aaron Capsel News  Aaron Capsel on Facebook
VP - Sales
Jeffrey Francis
  Jeffrey Francis LinkedIn Profile  Jeffrey Francis Twitter Account  Jeffrey Francis News  Jeffrey Francis on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/19/2020: Attestiv venture capital transaction
Next: 3/19/2020: VXG venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary